UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Bayer’s endometriosis treatment receives expanded insurance benefit
Bayer Korea said Tuesday that the Ministry of Health and Welfare has decide...
by Lee Han-soo
|
2018-12-11 17:12
라인
LG Chem, Avacta to develop new protein-based treatment
LG Chem said Tuesday that it has signed an agreement with Avacta, a U.K.- b...
by Lee Han-soo
|
2018-12-11 13:29
라인
Servier Korea fails to fix packaging error
Servier Korea received a warning from the Ministry of Food and Drug Safety ...
by Lee Hye-seon
|
2018-12-11 10:49
라인
Distributed drugs exceeded ₩60 trillion for 1st time in 2017
The amount of locally distributed pharmaceutical finished goods exceeded 60...
by Song Soo-youn
|
2018-12-10 16:31
라인
‘Novartis’ Entresto can lower readmission and fatality’
A local heart failure expert said Friday that Novartis’ Entresto, a chronic...
by Lee Han-soo
|
2018-12-07 17:39
라인
Ministry OKs Takeda’s lung cancer treatment
Takeda Korea said Wednesday that the Ministry of Food and Drug Safety has a...
by Lee Han-soo
|
2018-12-07 15:31
라인
AbbVie to test rheumatoid arthritis drug’s efficacy in ulcerative colitis
AbbVie said it would conduct a phase-3 clinical trial on upadacitinib, a tr...
by Lee Hye-seon
|
2018-12-07 15:29
라인
Hanmi to apply to FDA for approval of new bio drug
Hanmi Pharmaceutical said Friday that it plans to submit a biologics licens...
by Lee Han-soo
|
2018-12-07 14:54
라인
Side effects of breast fillers warned
After Japanese women reported side effects of breast enlargement surgeries ...
by Lee Hye-seon
|
2018-12-06 15:58
라인
Local drugmakers rank high in clinical trial approval
Domestic pharmaceutical companies took up over half of the top 20 drugmaker...
by Nam Doo-hyun
|
2018-12-06 11:15
라인
AstraZeneca’s immunotherapy Imfinzi arrives in Korea
AstraZeneca’s immunotherapy Imfinzi (ingredient: durvalumab) won domestic s...
by Lee Hye-seon
|
2018-12-05 17:12
라인
‘New combo drug could lower blood pressure early’
Amid an increase of hypertension drug prescriptions, new hypertension combi...
by Nam Doo-hyun
|
2018-12-05 14:01
라인
Janssen’s treatment on Crohn’s disease to get coverage
Janssen Pharmaceutical said Wednesday that the Ministry of Health and Welfa...
by Lee Han-soo
|
2018-12-05 11:03
라인
Bristol-Myers, Pfizer unveil real-world data for cardiovascular drug
Bristol-Myers Squibb and Pfizer have presented data comparing the safety an...
by Lee Han-soo
|
2018-12-04 18:31
라인
Roche’s lung cancer treatment gets extended reimbursement
Roche Korea said Tuesday that Alecensa, its target immunotherapy for lung c...
by Lee Han-soo
|
2018-12-04 14:32
라인
Ministry OKs trials for Genexine’s combo treatment of breast cancer
Genexine said Monday that the Ministry of Food and Drug Safety (MFDS) has a...
by Lee Han-soo
|
2018-12-04 11:44
라인
Hugel becomes 1st Korean firm to launch BTX product in Taiwan
Hugel said Tuesday that it has received sales approval from the Taiwan Food...
by Lee Han-soo
|
2018-12-04 11:43
라인
Pfizer’s rheumatoid arthritis drug adds indication for ulcerative colitis
Pfizer Korea said it won approval for Xeljanz Tab. 10mg (tofacitinib citrat...
by Lee Hye-seon
|
2018-12-04 11:17
라인
Medpacto unveils clinical trial on immunotherapy at US conference
Medpacto, a subsidiary of Theregen ETEX, said Monday that it has presented ...
by Lee Han-soo
|
2018-12-04 09:27
라인
Genexine releases clinical trial result of immunotherapeutic drug candidate
Genexine and NeoImmuneTech said Monday it has presented the results of its ...
by Lee Han-soo
|
2018-12-03 16:05
-
이전
61
62
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top